Companies - May 19, 2015
Lundbeck, Others Call for MDD in Dictionaries
A petition supported byTakeda Pharmaceuticals U.S.A., Inc. and Lundbeck U.S. calls on popular dictionaries, including Oxford Dictionary and Dictionary.com, to consider including Major Depressive Disorder (MDD) and all of the symptoms associated with it in their dictionaries. The goal of the petition is to bring greater awareness to the disorder and its symptoms. The word […]
Companies - April 15, 2015
Elocta Gets Orphan Status
Swedish Orphan Biovitrum AB has received orphan drug designation in Switzerland for its long acting hemophilia drug candidate Elocta (rFVIIIFc), developed for the treatment of hemophilia A. An orphan drug designation encourages the development of medicines for rare diseases and provides orphan status to drugs and biologics under development. Elocta is a long-acting recombinant factor […]
Companies - April 15, 2015
Novo Extends Diabetes Aid
Novo Nordisk has extended its Changing Diabetes® in Children program for another three years, according to a company announcement. Since 2009, the company has provided free insulin and access to diabetes care to more than 13,000 children in nine countries in Africa and Southeast Asia. In addition, 108 diabetes clinics have been established and 5,479 healthcare […]
Companies - April 2, 2015
Support for Hemophilia Patients
Novo Nordisk has launched a comprehensive patient support program, NovoSecure, for people with hemophilia. Eligible patients can apply for assistance including career counseling and HeroPath life coaching, which are specifically tailored to help patients address the often overlooked aspects of living with a chronic disease. NovoSecure was created as a result of information obtained through […]
Companies - March 23, 2015
Cortendo Names Board Members
John H. Johnson has been appointed chairman of the Cortendo AB board of directors and Richard Kollender named a director. The appointments were proposed by the nomination committee and approved by shareholders during the Extraordinary General Meeting on March 17. “We welcome the additions of John and Rich to Cortendo’s board of directors,” said Matthew […]
Companies - March 20, 2015
Zealand Pharma Reorganizes
Denmark’s Zealand Pharma has announced changes to its company’s organization and management structures. The research and development organization has been split into two parts, each with direct representation in management. In addition, investor relations & communications also will be represented directly at management level. The reorganization eliminates one management level to help streamline operations and […]
